MEGAN THOMAS: Open Payments
NPI 1811492242 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 8 payments from 6 companies in 2025. Trend: 2023 $1,526 · 2024 $1,469 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $144 |
| Janssen Biotech, Inc. | 1 | $122 |
| ABBVIE INC. | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: ZIIHERA, RYBREVANT, IMBRUVICA, AYVAKIT, KISQALI, EPKINLY.
Industry payments across CA — which companies pay providers there.
